{
    "nctId": "NCT05297643",
    "briefTitle": "Effects of Extracorporeal Shock Wave Therapy Added To Complex DecongestiveTherapy In Pat\u0131ent With Lymphedeme",
    "officialTitle": "Effects of Extracorporeal Shock Wave Therapyy Added To Complex DecongestiveTherapy In Patient With Breast Cancer Releated Lymphedema",
    "overallStatus": "RECRUITING",
    "conditions": "Lymphedema, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 44,
    "primaryOutcomeMeasure": "Evaluation of Pain;",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Be over 18 years old\n2. History of lymphedema for at least 6 months after breast cancer treatment\n3. Ending radiotherapy treatment at least 2 months ago\n4. Not being included in the Complex DecongestiveTherapy program within 3 months\n5. Having unilateral lymphedema\n6. Having stage 2 lymphedema\n7. Signing of the voluntary consent form\n8. Patients who have undergone oncological follow-up for breast cancer in the last 6 months and have been shown to be free of recurrence and metastasis\n\nExclusion Criteria:\n\n1. Active cancer\n2. Skin infection, radiotherapy burn\n3. Severely affected upper extremity range of motion 4 kidney failure\n\n5. Heart failure 6. History of untreated deep venous thrombosis 7. Body mass index I\u226535 kg/m2 8. Using a pacemaker/internal defibrillator 9. Patients continuing radiotherapy and/or chemotherapy treatment 10. Having bilateral lymphedema 11. Pregnancy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}